Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Specialty1 Partners is investing in AI tools for clinical documentation, patient communication, insurance administration and business operations across its dental practice network.
Researchers analyzed how 950,000 US clinicians used OpenEvidence from January 2024 to June 2026. Most queries concerned clinical decisions, particularly treatment and patient management.
OpenAI's Rosalind Academic Plan gives eligible US university biology labs up to 30 sponsored seats for one year, including access to GPT-Rosalind.
The MHRA plans to use AI to detect medicine safety signals earlier, improve clinical trial applications and clarify rules for AI medical products.
Jean Luc Neptune will lead clinical strategy across Reveleer's risk adjustment, quality and member management programs, which serve 12 million covered lives.
Tucuvi joins the Microsoft for Startups Pegasus Program to expand access to its clinical voice AI platform across health systems.
Zealand Pharma will use Generate:Biomedicines' generative AI platform to develop protein treatments for obesity and metabolic diseases under a deal worth up to $1.2 billion.
Waterdrop's 2025 ESG report says its KEYI.AI underwriting system reduced processing time for complex health insurance cases by 80% and achieved 99.8% accuracy.
Sunbound acquired Richter Healthcare Consultants and closed a $24 million Series A round led by TTV Capital. The deal adds revenue cycle, accounting and consulting services for senior care operators to Sunbound's software platform.
SciBase secured its first medical policy from a private US insurer covering the use of Nevisense to assess certain suspicious skin lesions.
TumorSight Risk analyzes breast MRI, pathology and clinical data to estimate recurrence risk at five and ten years for certain patients with early stage breast cancer.
HIMSS27 will take place April 5 to 8, 2027, in Chicago, with more than 600 education sessions and over 900 exhibitors.
wisepatientAI now lets patients ask questions about their medical history and receive answers based on records collected from multiple providers.
GenoMorph identified about 2,300 regulatory DNA candidates associated with bird beak size and shape, providing targets for testing in the dodo restoration program.
Likang Life Sciences will present its AI based neoantigen discovery platform at the Abu Dhabi Future Health Summit 2026, held October 20 to 22.
INmune Bio and Quantum Computing Inc. will use quantum optimization, AI and data analytics to identify potential disease indications and biomarkers for the investigational treatment XPro.
WeInfuse and Clarion have partnered to connect AI agents with infusion and pharmacy data. The agents handle routine patient calls using current order, authorization and appointment information.
Brainomix and the Pulmonary Fibrosis Foundation will study how patients and caregivers understand quantitative CT results from the e-Lung imaging tool.
Illumina launched a unified software environment that combines genomic analysis applications, AI models and curated biological data.
PhaseV says its causal model predicted weight changes, adverse events and treatment dropout among patients taking GLP-1 and related incretin medications.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
